A brain-computer interface (BCI) also known as a neural-control interface, is a direct communication pathway between an enhanced or wired brain and an external device. BCI translates brain signals into electronic signals that allow control of devices like prosthetic limbs, wheelchairs, or computer cursors with thought. BCIs allow people who cannot communicate through normal means to control external devices once again. BCI serves as a useful tool for medical applications like stroke rehabilitation and epilepsy. By using BCIs, the brain signals produced by thoughts of motion can trigger prosthetics or control a wheelchairs movement.
The global Brain Computer Interface Market is estimated to be valued at US$ 959.29 Mn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
Medical applications present a huge growth opportunity for the Brain Computer Interface market. BCIs help rehabilitate patients suffering from stroke and spinal cord injuries by enabling control over prosthetic devices through thought. This improves their mobility and quality of life. BCIs are also used to identify seizure activity in epileptic patients weeks before the actual seizure occurs. This early detection helps physicians better manage epilepsy and prevent complications. As the geriatric population prone to such neurological disorders increases, the demand for BCIs in healthcare will see a parallel rise. Their ability to restore lost motor functions and improve treatment outcomes makes BCI a promising area for medical research and innovation.
Porter's Analysis
Threat of new entrants: The threat of new entrants in the brain computer interface market is moderate. Establishing manufacturing facilities and gaining regulatory approvals require huge investments and clinical trials which act as barriers.
Bargaining power of buyers: The bargaining power of buyers is high as the market has several established international players offering substitutable and innovative products.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as they are few in numbers and involved in production of specialised components for BCIs.
Threat of new substitutes: The threat of substitutes is moderate as new applications of BCIs in gaming and augmented reality are evolving while established alternatives are present for certain medical applications.
Competitive rivalry: The competitive rivalry in the brain computer interface market is high due to presence of global players investing in R&D to enhance product offerings.
SWOT Analysis
Strength: BCIs offer non-invasive alternatives to disabled patients for communication and control. Existing applications in gaming and media are generating revenues.
Weakness: Limited clinical evidence, high product and therapy costs restrict mass adoption. Invasive procedures carry health risks.
Opportunity: Untapped markets in dementia, stroke and epilepsy patient care present expansion opportunities. Integration of AI and next-gen materials can spur innovations.
Threats: Regulatory approvals are stringent and lengthy. Ethical issues around data privacy and security arise from direct brain-machine links.
Key Takeaways
The global Brain Computer Interface Market Share is expected to witness high growth during the forecast period. The global Brain Computer Interface Market is estimated to be valued at US$ 959.29 Mn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030.
North America currently dominates the regional market for BCIs due to presence of major players and favorable reimbursement policies for assistive devices. The Asia Pacific region is anticipated to be the fastest growing market over the coming years led by rising disability population, increasing healthcare expenditures and emergence of local startups.
Key players operating in the brain computer interface market are Neuralink Corporation, Neurable, Emotiv Inc., BitBrain, Alpha Omega, Blackrock Microsystems, LLC, Femtonics Ltd, NeuroNexus, Opto Circuits (India) Limited, BIOTRONIK, Plexon Inc., Noldus Information Technology, NextMind, Nectome, and Paradromics. Neuralink Corporation is a leading player focused on developing BCIs for paralyzed patients using ultra high-density electrode arrays. Blackrock Microsystems, LLC offers research-grade BCIs based on implanted microelectrode arrays.
For more insights, read- https://www.newsanalyticspro.com/brain-computer-interface-market-trends-size-and-share-analysis/
